For disc herniations where inflammation drives both pain and degeneration, omega-3s provide baseline anti-inflammatory support that complements the anti-inflammatory effects of peptides
It demonstrated increased efficiency of oxidative phosphorylation in rat mitochondria in vitro and possible antioxidant effects are also attributed to it
That said, several important safety considerations remain: No FDA approval : BPC-157 is not approved by the U.S
[122] demonstrated that carnitine worsened the recovery of contractile function in transient ischemia
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Helps protect peptides from breaking down too early